tiprankstipranks
Marinomed Biotech AG (DE:93Z)
MUNICH:93Z
Germany Market

Marinomed Biotech AG (93Z) Financial Statements

0 Followers

Marinomed Biotech AG Financial Overview

Marinomed Biotech AG's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Marinomed Biotech AG is scheduled to report earnings on May 22, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue€ 4.18M€ 2.20M€ 2.49M€ 2.41M€ 5.91M
Gross Profit€ 896.00K€ 352.70K€ 412.30K€ 479.80K€ 2.86M
EBIT€ -85.10K€ -1.31M€ -1.25M€ -1.24M€ 1.01M
EBITDA€ 84.00K€ -1.14M€ -1.08M€ -1.07M€ 1.18M
Net Income Common Stockholders€ -608.90K€ -1.95M€ -2.00M€ -1.84M€ 411.60K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 8.18M€ 9.50M€ 11.04M€ 11.68M€ 5.80M
Total Assets€ 22.29M€ 23.73M€ 25.07M€ 25.80M€ 21.34M
Total Debt€ 22.63M€ 23.01M€ 22.69M€ 22.27M€ 15.80M
Net Debt€ 14.45M€ 13.51M€ 11.65M€ 10.60M€ 10.00M
Total Liabilities€ 26.44M€ 27.28M€ 27.00M€ 26.40M€ 21.15M
Stockholders Equity€ -4.16M€ -3.55M€ -1.93M€ -604.50K€ 191.40K
Cash Flow-
Free Cash Flow€ -1.70M€ -1.35M€ -1.39M€ -979.50K€ -957.40K
Operating Cash Flow€ -1.48M€ -1.49M€ -1.25M€ -979.50K€ -38.60K
Investing Cash Flow€ -47.90K€ -39.00K€ -78.80K€ -41.80K€ -117.50K
Financing Cash Flow€ 195.90K€ -4.10K€ 695.90K€ 6.90M€ 1.50M
Currency in EUR

Marinomed Biotech AG Earnings and Revenue History

Marinomed Biotech AG Debt to Assets

Marinomed Biotech AG Cash Flow

Marinomed Biotech AG Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis